These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1110955)

  • 1. [Agglutination titer of isoagglutinins in blood serum in cases of malignant neoplasms following zymosan stimulation].
    Dobrek A; Maciejewski B; Majewski S
    Pol Tyg Lek; 1975 Jan; 30(3):93-6. PubMed ID: 1110955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of non-specific stimulation with zymosan on serum properdin level in patients with neoplasms].
    Dobrek Z; Majewski S; Maciejewski B
    Pol Tyg Lek; 1972 Jul; 27(24):905-8. PubMed ID: 5040537
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of host organism on Zymosan application. (A clinical study).
    Cron J
    Neoplasma; 1970; 17(6):613-9. PubMed ID: 5507475
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of stimulation with Zymosan on the total complement level in lung cancer and tuberculosis.
    Cron J
    Neoplasma; 1973; 20(2):197-202. PubMed ID: 4707840
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood serum properdin as an index of nonspecific reactivity of the organism in patients with lung cancer].
    Dotsenko AP
    Vrach Delo; 1967 Dec; 12():107-8. PubMed ID: 5619412
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental alteration of rat lung clearance patterns by zymosan injection.
    Thomas RG; Chiffelle TL
    J Reticuloendothel Soc; 1974 Jan; 15(1):48-60. PubMed ID: 4810601
    [No Abstract]   [Full Text] [Related]  

  • 7. A contribution to the role of properdin in anticancer defence of the organism.
    Cron J
    Neoplasma; 1970; 17(2):155-68. PubMed ID: 5425393
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum seromucoid levels in patients with neoplasms and in cases of radiation-induced necrosis following non-specific stimulation with zymosan].
    Dobrek Z; Majewski S; Maciejewski B
    Pol Tyg Lek; 1973 Nov; 28(48):1886-9. PubMed ID: 4768257
    [No Abstract]   [Full Text] [Related]  

  • 9. [Properdin research. 1. Review of the properdin system and its problems; determination possibilities, assay of sera with high titer levels].
    Zimmermann G
    Arch Exp Veterinarmed; 1972; 26(2):221-46. PubMed ID: 4562974
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on properdin].
    Pfordte K
    Z Naturforsch B; 1966 Jan; 21(1):56-8. PubMed ID: 4382384
    [No Abstract]   [Full Text] [Related]  

  • 11. [Properdin titer following zymosan vaccination in cattle].
    ZIMMERMANN G; HARM M; SCHUTZLER H
    Acta Biol Med Ger; 1963; 10():426. PubMed ID: 14003717
    [No Abstract]   [Full Text] [Related]  

  • 12. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumour-inhibiting effect of properdin.
    Pfordte K; Ponsold W
    Neoplasma; 1969; 16(6):609-12. PubMed ID: 5369027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the titer of blood group isoagglutinins with the aging of the test erythrocytes and sera].
    Licenziati M; De Biasi R; Rubertelli M
    Riv Emoter Immunoematol; 1965; 12(1):37-51. PubMed ID: 5870744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aspecific immunological factors and sensitivity to pneumoconioses].
    Jarry JJ; Quinot E; Claeys C
    Med Lav; 1963 May; 54(5):438-59. PubMed ID: 4168252
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood serum protein fractions and properdin titer in patients with cancer of the gastrointestinal tract].
    Dotsenko AP
    Vrach Delo; 1971 Nov; 11():84-9. PubMed ID: 5143290
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukocyte induced pulmonary damage using intraperitoneal zymosan.
    Chiara O; Giomarelli PP; Borrelli E; Betti S; Padalino P; Nespoli A
    Prog Clin Biol Res; 1989; 308():73-6. PubMed ID: 2780724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relations between properdin and tumor resistance].
    Pfordte K
    Z Gesamte Hyg; 1970 Jun; 16(6):450-8. PubMed ID: 5512283
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
    ZSEBOK Z; WACHTL I; SZY S; SELLEI G
    Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation-induced changes in the properdin system of the dog and a critical analysis of the general problem.
    Michaelson SM; Shively JN; Haydock IC
    Radiat Res; 1966 May; 28(1):60-70. PubMed ID: 5931752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.